» Articles » PMID: 34084775

Co-Transmission of Alpha-Synuclein and TPPP/p25 Inhibits Their Proteolytic Degradation in Human Cell Models

Overview
Specialty Biology
Date 2021 Jun 4
PMID 34084775
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The pathological association of alpha-synuclein (SYN) and Tubulin Polymerization Promoting Protein (TPPP/p25) is a key factor in the etiology of synucleinopathies. In normal brains, the intrinsically disordered SYN and TPPP/p25 are not found together but exist separately in neurons and oligodendrocytes, respectively; in pathological states, however, they are found in both cell types due to their cell-to-cell transmission. The autophagy degradation of the accumulated/assembled SYN has been considered as a potential therapeutic target. We have shown that the hetero-association of SYN with TPPP/p25 after their uptake from the medium by human cells (which mimics cell-to-cell transmission) inhibits both their autophagy- and the ubiquitin-proteasome system-derived elimination. These results were obtained by ELISA, Western blot, FACS and immunofluorescence confocal microscopy using human recombinant proteins and living human cells; ANOVA statistical analysis confirmed that TPPP/p25 counteracts SYN degradation by hindering the autophagy maturation at the stage of LC3B-SQSTM1/p62-derived autophagosome formation and its fusion with lysosome. Recently, fragments of TPPP/p25 that bind to the interface between the two hallmark proteins have been shown to inhibit their pathological assembly. In this work, we show that the proteolytic degradation of SYN on its own is more effective than when it is complexed with TPPP/p25. The combined strategy of TPPP/p25 fragments and proteolysis may ensure prevention and/or elimination of pathological SYN assemblies.

Citing Articles

20S proteasome enhancers prevent cytotoxic tubulin polymerization-promoting protein induced α-synuclein aggregation.

Staerz S, Anamoah C, Tepe J iScience. 2024; 27(7):110166.

PMID: 38974969 PMC: 11225362. DOI: 10.1016/j.isci.2024.110166.


Perspective Strategies for Interventions in Parkinsonism: Remedying the Neglected Role of TPPP.

Olah J, Norris V, Lehotzky A, Ovadi J Cells. 2024; 13(4.

PMID: 38391951 PMC: 10886726. DOI: 10.3390/cells13040338.


The Sherpa hypothesis: Phenotype-Preserving Disordered Proteins stabilize the phenotypes of neurons and oligodendrocytes.

Norris V, Olah J, Krylov S, Uversky V, Ovadi J NPJ Syst Biol Appl. 2023; 9(1):31.

PMID: 37433867 PMC: 10336114. DOI: 10.1038/s41540-023-00291-8.


Functions and dysfunctions of oligodendrocytes in neurodegenerative diseases.

Han S, Gim Y, Jang E, Hur E Front Cell Neurosci. 2023; 16:1083159.

PMID: 36605616 PMC: 9807813. DOI: 10.3389/fncel.2022.1083159.


Modulatory Role of TPPP3 in Microtubule Organization and Its Impact on Alpha-Synuclein Pathology.

Olah J, Lehotzky A, Szenasi T, Berki T, Ovadi J Cells. 2022; 11(19).

PMID: 36230985 PMC: 9564178. DOI: 10.3390/cells11193025.


References
1.
Lehotzky A, Tirian L, Tokesi N, Lenart P, Szabo B, Kovacs J . Dynamic targeting of microtubules by TPPP/p25 affects cell survival. J Cell Sci. 2004; 117(Pt 25):6249-59. DOI: 10.1242/jcs.01550. View

2.
Dehay B, Bove J, Rodriguez-Muela N, Perier C, Recasens A, Boya P . Pathogenic lysosomal depletion in Parkinson's disease. J Neurosci. 2010; 30(37):12535-44. PMC: 6633458. DOI: 10.1523/JNEUROSCI.1920-10.2010. View

3.
Lilienbaum A . Relationship between the proteasomal system and autophagy. Int J Biochem Mol Biol. 2013; 4(1):1-26. PMC: 3627065. View

4.
Tokesi N, Olah J, Hlavanda E, Szunyogh S, Szabo A, Babos F . Identification of motives mediating alternative functions of the neomorphic moonlighting TPPP/p25. Biochim Biophys Acta. 2014; 1842(4):547-57. DOI: 10.1016/j.bbadis.2014.01.009. View

5.
Zaffagnini G, Savova A, Danieli A, Romanov J, Tremel S, Ebner M . Phasing out the bad-How SQSTM1/p62 sequesters ubiquitinated proteins for degradation by autophagy. Autophagy. 2018; 14(7):1280-1282. PMC: 6103668. DOI: 10.1080/15548627.2018.1462079. View